These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 25373115)

  • 1. Metabolic syndrome in a French cohort of patients with bipolar disorder: results from the FACE-BD cohort.
    Godin O; Etain B; Henry C; Bougerol T; Courtet P; Mayliss L; Passerieux C; Azorin JM; Kahn JP; Gard S; Costagliola D; Leboyer M;
    J Clin Psychiatry; 2014 Oct; 75(10):1078-85; quiz 1085. PubMed ID: 25373115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Drawing up guidelines for the attendance of physical health of patients with severe mental illness].
    Saravane D; Feve B; Frances Y; Corruble E; Lancon C; Chanson P; Maison P; Terra JL; Azorin JM;
    Encephale; 2009 Sep; 35(4):330-9. PubMed ID: 19748369
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic syndrome and obsessive-compulsive disorder: a naturalistic Italian study.
    Albert U; Aguglia A; Chiarle A; Bogetto F; Maina G
    Gen Hosp Psychiatry; 2013; 35(2):154-9. PubMed ID: 23158675
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic syndrome in bipolar disorder: a cross-sectional assessment of a Health Management Organization database.
    Sicras A; Rejas J; Navarro R; Serrat J; Blanca M
    Bipolar Disord; 2008 Jul; 10(5):607-16. PubMed ID: 18657245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modal subcomponents of metabolic syndrome in patients with bipolar disorder.
    Cardenas J; Frye MA; Marusak SL; Levander EM; Chirichigno JW; Lewis S; Nakelsky S; Hwang S; Mintz J; Altshuler LL
    J Affect Disord; 2008 Feb; 106(1-2):91-7. PubMed ID: 17628693
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of Metabolic Syndrome and Associated Factors in a Cohort of Individuals With Treatment-Resistant Depression: Results From the FACE-DR Study.
    Godin O; Bennabi D; Yrondi A; Richieri R; D'Amato T; Bellivier F; Bougerol T; Horn M; Camus V; Courtet P; Doumy O; Genty JB; El-Hage W; Haesebaert F; Holtzmann J; Lancon C; Leboyer M; Llorca PM; Maruani J; Molière F; Samalin L; Schmitt L; Stephan F; Vaiva G; Aouizerate MWB; Haffen E;
    J Clin Psychiatry; 2019 Oct; 80(6):. PubMed ID: 31617968
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Who are patients suffering from bipolar disorders in France? The TEMPPO survey: patients' sociodemographic and clinical characteristics data].
    de Carvalho W; Nuss P; Blin P; Arnaud R; Filipovics A; Loze JY; Dillenschneider A
    Encephale; 2012 Jun; 38(3):211-23. PubMed ID: 22726409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bipolar disorder and metabolic syndrome: comorbidity or side effects of treatment of bipolar disorder.
    Babić D; Maslov B; Martinac M; Nikolić K; Uzun S; Kozumplik O
    Psychiatr Danub; 2010 Mar; 22(1):75-8. PubMed ID: 20305595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of diabetes and the metabolic syndrome in a sample of patients with bipolar disorder.
    van Winkel R; De Hert M; Van Eyck D; Hanssens L; Wampers M; Scheen A; Peuskens J
    Bipolar Disord; 2008 Mar; 10(2):342-8. PubMed ID: 18271914
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patients taking medications for bipolar disorder are more prone to metabolic syndrome than Korea's general population.
    Lee NY; Kim SH; Cho B; Lee YJ; Chang JS; Kang UG; Kim YS; Ahn YM
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Oct; 34(7):1243-9. PubMed ID: 20599461
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic syndrome and metabolic abnormalities in bipolar disorder: a meta-analysis of prevalence rates and moderators.
    Vancampfort D; Vansteelandt K; Correll CU; Mitchell AJ; De Herdt A; Sienaert P; Probst M; De Hert M
    Am J Psychiatry; 2013 Mar; 170(3):265-74. PubMed ID: 23361837
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prevalence of metabolic syndrome in patients with bipolar disorder.
    Garcia-Portilla MP; Saiz PA; Benabarre A; Sierra P; Perez J; Rodriguez A; Livianos L; Torres P; Bobes J
    J Affect Disord; 2008 Feb; 106(1-2):197-201. PubMed ID: 17631970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atypical antipsychotics related metabolic syndrome in bipolar patients.
    Yumru M; Savas HA; Kurt E; Kaya MC; Selek S; Savas E; Oral ET; Atagun I
    J Affect Disord; 2007 Mar; 98(3):247-52. PubMed ID: 16970993
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of bipolar disorders and metabolic syndrome: implications for primary care.
    Bell PF; McKenna JP; Roscoe BM
    Postgrad Med; 2009 Sep; 121(5):140-4. PubMed ID: 19820282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Seasonal pattern in bipolar disorders and cardio-vascular risk factors: A study from the FACE-BD cohort.
    Geoffroy PA; Godin O; Mahee D; Henry C; Aubin V; Azorin JM; Bougerol T; Courtet P; Gard S; Kahn JP; Passerieux C; Leboyer M; Bellivier F; Etain B;
    Chronobiol Int; 2017; 34(7):845-854. PubMed ID: 28537802
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Bipolar disorders and metabolic syndrome: a clinical study in 185 patients].
    Maina G; D'Ambrosio V; Aguglia A; Paschetta E; Salvi V; Bogetto F
    Riv Psichiatr; 2010; 45(1):34-40. PubMed ID: 20380240
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medical risk in patients with bipolar disorder and schizophrenia.
    Newcomer JW
    J Clin Psychiatry; 2006; 67 Suppl 9():25-30; discussion 36-42. PubMed ID: 16965186
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The prevalence of metabolic syndrome and its association with alanine aminotransferase in clozapine-treated Korean patients with schizophrenia.
    Lee NY; Roh MS; Kim SH; Jung DC; Yu HY; Sung KH; Chung IW; Youn T; Kang UG; Ahn YM; Kim YS
    Int Clin Psychopharmacol; 2013 Mar; 28(2):71-9. PubMed ID: 23211493
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased prevalence of metabolic syndrome in patients with bipolar disorder compared to a selected control group-a Northern Netherlands LifeLines population cohort study.
    Schuster MP; Borkent J; Chrispijn M; Ioannou M; Doornbos B; Burger H; Haarman BCM
    J Affect Disord; 2021 Dec; 295():1161-1168. PubMed ID: 34706429
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of insulin resistance, metabolic syndrome and adiponectin in overweight bipolar patients taking sodium valproate and controls.
    Elmslie JL; Porter RJ; Joyce PR; Hunt PJ; Shand BI; Scott RS
    Aust N Z J Psychiatry; 2009 Jan; 43(1):53-60. PubMed ID: 19085528
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.